The largest database of trusted experimental protocols

Cimetidine

Cimetidine is a histamine H2-receptor antagonist used in the treatment of peptic ulcer disease.
It works by reducing the production of stomach acid, allowing the ulcer to heal.
Cimetidine has also been investigated for its potential use in other conditions, such as gastroesophageal reflux disease and the prevention of stress-induced ulcers.
Researchers can leverage PubCompare.ai's AI-driven platform to optimize their Cimetidine studies, locating protocols from a vast database and utilizing powerful comparison tools to identify the most reproducible and accurat protocols and products, boosting research effeciency and enhancing reproducibility.

Most cited protocols related to «Cimetidine»

We recruited adults aged over 18 years to sign informed consents from the Kaohsiung Medical University Hospital and the National Taiwan University Hospital. Subjects with acute renal failure, allergy to inulin, pregnancy, problems in voiding, amputation, congestive heart failure, cirrhosis with ascites, use of cimetidine or trimethoprim, oliguria, and those who had ever received any renal replacement therapy were excluded. Healthy volunteers were enrolled according to the percentage of age distribution in Taiwanese reported by the Ministry of the Interior of Taiwan. CKD was diagnosed and classified according to the K/DOQI clinical guidelines [1] (link). The ratio of the number of the CKD patients to healthy volunteers was approximately 2∶1 in this study.
Full text: Click here
Publication 2014
Adult Amputation Ascites Cimetidine Congestive Heart Failure Healthy Volunteers Hypersensitivity Inulin Kidney Failure, Acute Liver Cirrhosis Oliguria Patients Pregnancy Renal Replacement Therapy Trimethoprim
Treatment-seeking adults (aged 18–65) smoking ≥10 cigarettes per day for the past six months responded to advertisements for a smoking cessation clinical trial (NCT01314001). Exclusion criteria included the use of chewing tobacco, snuff or snus; recent treatment for substance abuse; current cocaine or opiate abuse; the consumption of >25 standard alcoholic drinks/week; current depression, mania, schizophrenia, or post-traumatic stress disorder; recent use of anti-psychotics, anti-depressants, prescription stimulants, metformin, cimetidine, cardiac medications, or other anti-coagulants; and the daily use of prescription opiates/inhalers. Those interesting in participating after meeting eligibility criteria provided a blood sample for NMR determination, collected when participants were smoking as usual. The detailed study protocol, including NMR determination, is described in a previous analysis of NMR and three self-report measures of nicotine dependence in a subset of the trial participants (N=833 of 1807 screened by NMR) [19 ]. Briefly, cotinine and 3′hydroxycotinine were assessed from whole blood by liquid chromatography-tandem mass spectrometry (LC/MS-MS) using a previously validated method [41 , 42 (link)]. NMR data were available on a total of 1807 eligible participants screened at the four clinical sites: the University of Pennsylvania (N=487), the Centre for Addiction and Mental Health (CAMH) at the University of Toronto (N=430), the MD Anderson Cancer Center (N=443) and the University at Buffalo, SUNY (N=447). Survey data on demographic variables (including age, gender, ethnicity) and smoking history were collected, as well as height and weight measurements in order to compute BMI. Data were also collected from female participants on the use of oral contraceptives and hormone replacement therapies. Data on mentholated cigarette use was collected from the subset of participants in the intent-to-treat (ITT) group (N=1155), assessed when they received their study medication and completed the first counseling session. Informed consent was obtained from each participant. The study was approved by Institutional Review Boards at each site.
Publication 2014
Addictive Behavior Adult Alcoholic Beverages BLOOD Buffaloes Central Nervous System Stimulants Cimetidine Coagulants Cocaine Contraceptives, Oral Cotinine Eligibility Determination Ethics Committees, Research Ethnicity Gender Heart hydroxycotinine Inhaler Liquid Chromatography Malignant Neoplasms Mania Mental Disorders Mental Health Metformin Mint Snuff Nicotine Dependence Opiate Abuse Opiate Alkaloids Pharmaceutical Preparations Post-Traumatic Stress Disorder Schizophrenia Snus Substance Abuse Tandem Mass Spectrometry Therapy, Hormone Replacement Woman
Litters of two-day old New Zealand White infant rabbits with the lactating doe were acquired from a commercial breeder (Milbrook Farm, Amherst, MA). The following day, the infant rabbits were administered cimetidine (50 mg kg−1 via intraperitoneal injection; Hospira, IL) 3 hr prior to oro-gastric inoculation with either 1×109 cfu wild type V. parahaemolyticus, or one of the isogenic mutants, or sodium bicarbonate solution (2.5 g in 100 mL; pH 9) using a size 4 French catheter (Arrow International, Reading, PA). To prepare the inocula, cultures of bacteria grown for ∼18 hr at 30°C were harvested by centrifugation (5 mins 6000 g), and the cell pellet resuspended in sodium bicarbonate solution (pH 9) to a final concentration of 2×109 cfu mL−1. Following inoculation, the infant rabbits were monitored frequently for clinical signs of illness. Disease was scored at euthanasia as follows: no gross disease (no adherent fecal material on fur and intestines appear normal), intestinal fluid (no adherent fecal material on fur but intestines appeared red, swollen and contained fluid), diarrhea (liquid fecal material stains or adheres to fur, and intestines appeared red, swollen and contained fluid). In most experiments, rabbits were euthanized at fixed times after infection (i.e. 12, 18, 28 or 38 hr PI), but rabbits were euthanized prior to these time points if they appeared moribund (categorized as ‘dead’ in Table 1 and Figure 1A). At necropsy, the intestinal tract from the duodenum to the rectum was removed and processed for microbiological, microscopic and histologic analyses. For some rabbits, the internal organs including the gall bladder, spleen and liver were also collected, homogenized and plated on selective media to check for systemic spread of V. parahaemolyticus.
To determine fluid accumulation ratios (FARs), an approx. 5 cm length of the distal small intestine was isolated from the rest of the intestine using silk ligatures. The intestinal section was weighed and then cut every 0.5 cm to release any luminal fluid, and the tissue pieces reweighed. The FAR was calculated as the weight of fluid divided by the weight of the drained tissue. The electrolyte and protein concentrations in serum and diarrheal fluid collected from the ceca of infected rabbits were measured on an Olympus Analyzer (AU-2700) at the Brigham and Woman's Hospital clinical laboratory.
The number of V. parahaemolyticus cfu in tissue samples taken from the small and large intestine, cecum and stool were determined after homogenization, serial dilution and plating on LB media containing 50 µg mL−1 carbenicillin as described previously [24] (link). For unknown reasons, rabbits were occasionally not colonized by the pathogen i.e., no V. parahaemolyticus cfu were detected in any tissue sample. These rabbits (less than 10%, regardless of strain tested) were excluded from all further analyses. However, any rabbits that contained detectable numbers of V. parahaemolyticus cfu in at least one tissue sample were included; for these rabbits, the lower limit of detection was reported for sections where no colonies were detected at the lowest dilution plated, and this value was used in calculation of mean cfu.
For routine histological analyses, tissue segments were fixed in 10% neutral buffered formalin, processed for paraffin embedding and stained with hematoxylin and eosin (H&E). The slides were semi-quantitatively assessed for infiltration of inflammatory cells (heterophils), cell proliferation, and tissue damage by a pathologist blinded to the origin of the tissue. Each histological parameter was evaluated on a 0–4 scale as follows: 0 (normal), 1 (mild), 2 (moderate), 3 (severe) and 4 (severe and extensive).
Full text: Click here
Publication 2012
Animals Autopsy Bacteria Bicarbonate, Sodium Carbenicillin Catheters Cecum Cell Proliferation Cells Centrifugation Cimetidine Diarrhea Duodenum Electrolytes Eosin Euthanasia Feces Formalin Gallbladder Infant Infection Inflammation Injections, Intraperitoneal Intestines Intestines, Small Large Intestine Ligature Liver Microscopy New Zealand Rabbits Oryctolagus cuniculus pathogenesis Pathologists Patient Holding Stretchers Phenobarbital Rectum Serum Proteins Silk Spleen Staining Stomach Strains Technique, Dilution Tissues Vaccination
Participants who were older than 60 years were selected to measure GFR at the Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, China from Jan 2005 to Dec 2011. Patients with acute kidney function deterioration, clinical edema, skeletal muscle atrophy, pleural effusion or ascites, malnutrition, amputation, heart failure or ketoacidosis were excluded from the study. Participants that were taking cimetidine or trimethoprim were excluded as well. No subject was being treated with dialysis at the time of the study. Exclusion criteria were described elsewhere [6] (link). CKD was diagnosed and categorized according to the National Kidney Foundation Disease Outcomes Quality Initiative (NKF-K/DOQI) clinical practice guidelines [7] (link). The institutional review board of the Third Affiliated Hospital of Sun Yat-sen University approved the study. Written informed consent was obtained from each participant. A total of 668 elderly participants were included in this study, including 398 men and 270 women. The mean age was 70.0±6.7 yr (ranged from 60 to 93 yr), and the mean measured GFR (mGFR) was 51.2±26.0 ml/min/1.73 m2 (ranged from 6.6 to 134.1 ml/min/1.73 m2). Causes and GFR categories are listed in Table 1. The total cohort was randomly divided into the development data set (n = 433) and the validation data set (n = 235).
Full text: Click here
Publication 2013
Aged Amputation Ascites Atrophy Cimetidine Congestive Heart Failure Dialysis Edema Ethics Committees, Research Ketosis Kidney Kidney Diseases Malnutrition Patients Pleural Effusion Skeletal Muscles Trimethoprim Woman
Participants were recruited from nephrology and infectious disease clinics at Mt Sinai Hospital and St Vincent’s Medical Center in New York, Tufts Medical Center in Boston and University of Alabama at Birmingham, as well as from HIV community centers in Boston, Massachusetts. Eligible patients included those who were older than 18 years of age, on stable ART for at least three months, with confirmed HIV status and an HIV viral load and CD4 count within 6 months of recruitment. Patients were excluded if they were pregnant, had an allergy or other contraindication to use of iohexol or iodine, recent acute kidney injury, had cognitive or physical impairments or were on cimetidine. Patients were recruited who were and who were not on tenofovir as well as those with higher levels of serum creatinine.
Publication 2012
CD4+ Cell Counts Cimetidine Cognition Communicable Diseases Creatinine Hypersensitivity Iodine Iohexol Kidney Failure, Acute Patients Physical Examination Serum Tenofovir

Most recents protocols related to «Cimetidine»

Retention times of the analytes were measured with Shimadzu HPLC system on the CHIRALPAK®HAS stationary phase (50 × 3 mm, 5 μm, Chiral Technologies, DAICEL Group, Europe SAS, France). The mobile phase A consisted of 50 mM aqueous ammonium acetate buffer (pH 7.4) and phase B of 2-propanol according to Valko et al.65 (link) Analysis was performed at prolonged 1 mL min−1 flow rate in the linear gradient. Retention capacity factors (k′) were calculated by using DMSO or a substance with 0% HAS binding for systems' dead time (Rt0). The system was calibrated by injecting the reference compounds: acetylsalicylic acid (CAS 69-72-7), betamethasone (CAS 378-44-9), budesonide (CAS 5133-22-3), carbamazepine (CAS 298-46-4), cimetidine (CAS 51481-61-9), ciprofloxacin (CAS 85721-33-1), indomethacin (CAS 53-86-1), isoniazid (CAS 54-85-3), metronidazole (CAS 443-48-1), nicardipine (CAS 55985-32-5), nizatidine (CAS 76963-41-2) and warfarin (CAS 81-81-2) obtained from Sigma-Aldrich, diclofenac (CAS 15307-86-5) from EMD Chemicals Inc., flumazenil (CAS 78755-81-4) from ABX and ketoprofen (CAS 22071-15-4) from LKT Labs. The logarithmic capacity factors of the references' Rt (log(k′)) on the HSA column were plotted against the %PPB values from literature. The slope and the intercept were used to convert the log(k′) of the compounds (6a, c, f, h, m–o) to %PPB using the regression equation.66 (link)
Full text: Click here
Publication 2023
ammonium acetate Aspirin Betamethasone Budesonide Buffers Carbamazepine Cimetidine Ciprofloxacin Diclofenac Flumazenil High-Performance Liquid Chromatographies Indomethacin Isoniazid Ketoprofen Metronidazole Nicardipine Nizatidine Propanols Retention (Psychology) Sulfoxide, Dimethyl Warfarin
Apatinib was given as a fixed dose of 250 mg once a day, within 30 min after breakfast. Sintilimab was given within 60 min before chemotherapy by intravenous infusion of a fixed dose of 200 mg every 3 weeks. Antiemetic drugs were given by intravenous infusion 30 min before chemotherapy with either irinotecan (150 mg/m2, 90-minute intravenous infusion once every 2 weeks) or paclitaxel (150 mg/m2, 3-hour intravenous infusion once every 3 weeks). Considering that compared with monotherapy combination may increase the risk of toxic reactions, and chemotherapy is more important to play an immunomodulatory role in the combination therapy, the dose of chemotherapy drugs in this study was lowered compared with the conventional dose. Prophylactic atropine was given before the next irinotecan infusion treatment for patients with acute cholinergic syndrome. To prevent allergic reaction, 10 mg of oral dexamethasone was given 12 and 6 h before paclitaxel administration, and 400 mg of intravenous cimetidine and 50 mg of intramuscular diphenhydramine were given 30 min before paclitaxel administration. An intravenous infusion of sintilimab every 3 weeks is considered one cycle. Apatinib and sintilimab were continued until the disease progressed or became intolerable or up to 2 years, and the chemotherapy drug irinotecan or paclitaxel was continued until the disease progression, intolerable toxicity, or up to 6 months. If adverse events occurred during treatment, symptomatic and supportive treatments were given according to clinical protocol. Immune-related adverse events were treated with reference to the NCCN immune-related toxicity management guidelines. Blood or urine laboratory tests such as routine blood parameters, blood biochemistry, heart function, routine urinalysis, and thyroid function were regularly performed according to clinical protocol. Contrast-enhanced computed tomography of chest, abdomen, and pelvis was carried out every 6 weeks until progressive disease (PD) was confirmed. Response was determined by the investigators according to RECIST 1.1. Adverse events were assessed according to the National Cancer Institute Common Terminology Criteria for Adverse Events (CTCAE) version 5.0. Patients with PD after the study treatment were followed up every 3 months by telephone until death.
Full text: Click here
Publication 2023
4-maleimido-2,2,6,6-tetramethylpiperidinooxyl Abdomen Allergic Reaction Antiemetics apatinib Atropine BLOOD Chest Cholinergic Agents Cimetidine Clinical Protocols Combined Modality Therapy Condoms Dexamethasone Diphenhydramine Disease Progression Heart Hematologic Tests Immunomodulation Intravenous Infusion Irinotecan Paclitaxel Patients Pelvis Pharmaceutical Preparations Pharmacotherapy sintilimab Syndrome Thyroid Gland Urinalysis Urine X-Ray Computed Tomography
This was a quasi-experimental study with a pre-post design that analyzes the effect of Vitamin D analog supplementation in women with uterine prolapse. We included all postmenopausal women diagnosed with grade III and IV uterine prolapse who came to outpatient clinic of Dr. Hasan Sadikin Bandung from August 2021 to November 2021. Uterine prolapse diagnosis and staging were based on Pelvic Organ Prolapse Quantification (POP-Q) system. Exclusion criteria were as follows:

Patients with comorbidities, such as chronic cough and chronic constipation (these symptoms last for a minimum of 8 weeks).

Patients diagnosed with diseases related to Vitamin D metabolism disorders such as: diabetes mellitus, chronic kidney failure, or malignant diseases

Those who had a history of gastrectomy or jejunoileostomy surgery.

Patients who are currently or have a history of taking cholesterol-lowering drugs (statins and fibrates), anticonvulsants, thiazides, theophylline, orlistat, cimetidine, and Vitamin D supplementation one month prior to this study.

Patients withdrawing from our research.

During the initial presentation, we collected the following data: age, parity, body mass index (BMI), hemoglobin levels, and calcium levels. All subjects were then given 0.5 mcg of Vitamin D analog supplementation for 3 months. We also collected and compared the following data before and after Vitamin D analog supplementation: (1) Vitamin D and VDR serum levels, (2) Levator ani muscle strength, and (3) Hand grip muscle strength. Levator ani muscle strength was measured using perineometer, while handgrip muscle strength was evaluated using hand grip dynamometer.
We tabulated all patients' data on a customized spreadsheet and performed data analysis on Statistical Produce and Service Solutions SPSS software version 25 for Windows (IBM Corp, Armonk, New York, USA). Descriptive statistics were performed as appropriate. Analytical statistics were performed using t test or Wilcoxon test as required, with p < 0.05 considered as significant.
Written informed consent was provided to all study participants prior to engaging in any study-related procedures. Ethical approval of this study was granted by the Health Research Ethics Committee of Hasan Sadikin Hospital, Bandung under the following registration number: LB.02.01/X.6.5/213/2021. This study was conducted according to Declaration of Helsinki. All research procedures were performed in accordance with relevant guidelines and regulations.
Full text: Click here
Publication 2023
Anticholesteremic Agents Anticonvulsants Calcium, Dietary Cimetidine Constipation Cough Diabetes Mellitus Ergocalciferol Ethics Committees, Clinical Fibrates Gastrectomy Grasp Hemoglobin Hydroxymethylglutaryl-CoA Reductase Inhibitors Index, Body Mass Kidney Failure, Chronic Metabolic Diseases Muscle Strength Muscle Tissue Operative Surgical Procedures Orlistat Patients Pelvic Organ Prolapse Serum Theophylline Thiazides Uterine Prolapse Woman
IUR [40 (link)] were performed in triplicate with 2 × 105 cells per tube. Briefly, 2 × 105 cells were incubated for 2 h at 37 °C in the presence and absence of a 50% 14C-labeled 2 μM AZA. For IUR with inhibitors, 100 μM verapamil (Royal Adelaide Hospital Pharmacy, Adelaide, SA, Australia), 200 μM procainamide (Sigma-Aldrich, St. Louis, MO, USA), 10 μM corticosterone (Sigma-Aldrich, St. Louis, MO, USA), 20 μM NBMPR (Sigma-Aldrich, St. Louis, MO, USA), 20 μM cyclosporin A (Sigma-Aldrich, St. Louis, MO, USA), 10 μM chloroquine (Sigma-Aldrich, St. Louis, MO, USA), 150 μM amantadine (Sigma-Aldrich, St. Louis, MO, USA), 20 and 200 μM cimetidine (Sigma-Aldrich, St. Louis, MO, USA), and 0.1 and 10 μM pyrimethamine (Sigma-Aldrich, St. Louis, MO, USA) were added. After incubation the cellular and aqueous phases were separated, and incorporation determined using a Perkin Elmer Liquid Scintillation Analyser following the addition of Microscint 20 scintillation fluid (Perkin Elmer, Waltham, MA, USA) before counts per minute of β radiation in the supernatant and cell pellet fractions was used to convert to ng of AZA in 2 × 105 cells. All assays were performed in triplicate and repeated if the assay demonstrated non-concordance.
Full text: Click here
Publication 2023
4-nitrobenzylthioinosine Amantadine Beta Particle Biological Assay Cells Chloroquine Cimetidine Corticosterone Cyclosporine inhibitors Procainamide Pyrimethamine Verapamil
The streptomycin water ETEC colonization model was carried out as described previously [29 (link)]. Female CD1 mice aged 7–9 weeks from Charles River Laboratories were used for the ETEC colonization model. Upon arrival, mice were allowed to adapt to their housing for a minimum of 72 h before experimental intervention. Streptomycin (5 g/L) was provided in the drinking water 48 h before infection and withdrawn 24 h later. Food was withdrawn 18 h before infection. Cimetidine (1.0 mg) was administered intraperitoneally 1 h before infection. Deferoxamine-treated mice were given 0.6 mg deferoxamine orally 24 h before infection and again immediately before infection. Mice were orally infected with 108 CFU of appropriate inoculum strain. Weight change and fecal shedding of bacteria were monitored daily.
Full text: Click here
Publication 2023
Cimetidine Deferoxamine Enterotoxigenic Escherichia coli Feces Food Infection Mus Rivers Strains Streptomycin Woman

Top products related to «Cimetidine»

Sourced in United States, United Kingdom, Germany
Cimetidine is a laboratory product manufactured by Merck Group. It is a chemical compound used in various research and analytical applications.
Sourced in United States, Germany, United Kingdom, Brazil, Italy, Sao Tome and Principe, China, India, Japan, Denmark, Australia, Macao, Spain, France, New Zealand, Poland, Singapore, Switzerland, Belgium, Canada, Argentina, Czechia, Hungary
Indomethacin is a laboratory reagent used in various research applications. It is a non-steroidal anti-inflammatory drug (NSAID) that inhibits the production of prostaglandins, which are involved in inflammation and pain. Indomethacin can be used to study the role of prostaglandins in biological processes.
Sourced in United States, Germany, United Kingdom, Italy, Sao Tome and Principe, Spain, Macao, Canada, Brazil, France, Australia, Austria
Histamine is a laboratory equipment product manufactured by Merck Group. It is a chemical compound used in various research and analytical applications. Histamine plays a crucial role in biological processes and is commonly utilized in laboratories for testing and analysis purposes.
Sourced in United States, China, United Kingdom, Germany, Australia, Japan, Canada, Italy, France, Switzerland, New Zealand, Brazil, Belgium, India, Spain, Israel, Austria, Poland, Ireland, Sweden, Macao, Netherlands, Denmark, Cameroon, Singapore, Portugal, Argentina, Holy See (Vatican City State), Morocco, Uruguay, Mexico, Thailand, Sao Tome and Principe, Hungary, Panama, Hong Kong, Norway, United Arab Emirates, Czechia, Russian Federation, Chile, Moldova, Republic of, Gabon, Palestine, State of, Saudi Arabia, Senegal
Fetal Bovine Serum (FBS) is a cell culture supplement derived from the blood of bovine fetuses. FBS provides a source of proteins, growth factors, and other components that support the growth and maintenance of various cell types in in vitro cell culture applications.
Sourced in United States, Germany, Sao Tome and Principe, United Kingdom, Italy
Histamine dihydrochloride is a chemical compound used in laboratory settings. It is a white, crystalline powder that is soluble in water and other polar solvents. Histamine dihydrochloride is commonly used as a research tool in various scientific applications, such as in the study of histamine receptors and their role in physiological and pathological processes.
Sourced in United States
Pyrilamine is a type of laboratory equipment used in various research and analytical settings. It functions as a piece of equipment for chemical analysis and measurement. The core purpose of Pyrilamine is to provide accurate and reliable data collection during laboratory experiments and testing.
Sourced in United States, Germany, France, Belgium, Sao Tome and Principe, Japan, Italy, Canada, United Kingdom, Switzerland, Spain, Macao, Austria
Probenecid is a laboratory reagent used in the analysis of biological samples. It functions as a uricosuric agent, which helps to increase the excretion of uric acid from the body. Probenecid is commonly used in various biochemical and clinical applications, such as drug interaction studies and research on uric acid metabolism.
Sourced in United States, Germany, France, United Kingdom, China, Japan, Spain, Italy, Sao Tome and Principe, Switzerland, Australia, Ireland, Belgium
Verapamil is a laboratory product manufactured by Merck Group. It is a calcium channel blocker that inhibits the movement of calcium ions through cell membranes, which can affect various physiological processes. The core function of Verapamil is to serve as a research tool for the study of calcium-dependent mechanisms in biological systems.
Sourced in Japan
Cimetidine is a laboratory equipment product designed for use in various scientific and research applications. It serves as a chemical reagent with specific functional properties. The core function of Cimetidine is to provide a controlled and consistent chemical compound for experimental and analytical purposes. No further details on its intended use or applications are provided to maintain an unbiased and factual approach.
Sourced in Germany, United States, Italy, United Kingdom, France, Spain, China, Poland, India, Switzerland, Sao Tome and Principe, Belgium, Australia, Canada, Ireland, Macao, Hungary, Czechia, Netherlands, Portugal, Brazil, Singapore, Austria, Mexico, Chile, Sweden, Bulgaria, Denmark, Malaysia, Norway, New Zealand, Japan, Romania, Finland, Indonesia
Formic acid is a colorless, pungent-smelling liquid chemical compound. It is the simplest carboxylic acid, with the chemical formula HCOOH. Formic acid is widely used in various industrial and laboratory applications.

More about "Cimetidine"

Cimetidine, a Powerful H2-Receptor Antagonist for Ulcer Treatment and Beyond Cimetidine, a versatile pharmaceutical compound, has long been recognized for its efficacy in the treatment of peptic ulcer disease.
As a histamine H2-receptor antagonist, it works by reducing the production of stomach acid, allowing the ulcer to heal and preventing further damage.
Beyond its primary use in ulcer management, cimetidine has also been investigated for its potential applications in other gastrointestinal conditions, such as gastroesophageal reflux disease (GERD) and the prevention of stress-induced ulcers.
Researchers leveraging PubCompare.ai's AI-driven platform can optimize their cimetidine studies, tapping into a vast database of protocols and utilizing powerful comparison tools to identify the most reproducible and accurate approaches, boosting research efficiency and enhancing reproducibility.
Cimetidine's mechanism of action involves its ability to competitively inhibit the histamine H2 receptors, which play a crucial role in the regulation of gastric acid secretion.
This H2-receptor antagonism reduces the production of stomach acid, creating a more favorable environment for ulcer healing.
Interestingly, cimetidine has also been studied for its potential effects on other medical conditions, such as the management of indomethacin-induced gastric ulcers and the modulation of histamine-related responses.
To further enhance their cimetidine research, scientists can explore related compounds like histamine dihydrochloride, pyrilamine, and probenecid, which may offer additional insights into the pharmacological properties and potential applications of this versatile drug.
By incorporating these related terms and concepts, researchers can gain a deeper understanding of the broader landscape of cimetidine and its interactions with the gastrointestinal system.
PubCompare.ai's AI-driven platform provides a powerful tool for optimizing cimetidine studies, allowing researchers to access a vast database of protocols, pre-prints, and patents, and leverage advanced comparison tools to identify the most reproducible and accurate approaches.
This enhanced efficiency and reproducibility can significantly contribute to the advancement of cimetidine research and its clinical applications, ultimately benefiting patients suffering from ulcers and other gastrointestinal conditions.
OtherTerms: Cimetidine, H2-receptor antagonist, peptic ulcer disease, gastroesophageal reflux disease (GERD), histamine, indomethacin, histamine dihydrochloride, pyrilamine, probenecid, PubCompare.ai